CFO transition

AT&T Inc. CFO transition: Jennifer Biry to succeed Pascal Desroches

AT&T Inc. reported in a Form 8-K filed June 16, 2026 that Jennifer Biry will succeed Pascal Desroches as Senior Executive Vice President and Chief Financial Officer, effective January 1, 2027.

In the filing's words

On June 11, 2026, Pascal Desroches announced his retirement as Senior Executive Vice President and Chief Financial Officer of AT&T Inc. (the “Company”), which will be effective as of December 31, 2026. On June 15, 2026, the Company appointed Jennifer Biry as Deputy Chief Financial Officer, effective as of July 6, 2026.

Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.

CompanyAT&T Inc. (T)
EventTransition
IncomingJennifer Biry
OutgoingPascal Desroches
Title in the filingSenior Executive Vice President and Chief Financial Officer
EffectiveJanuary 1, 2027
8-K filedJune 16, 2026
Internal promotionNo
Prior role (per filing)Chief Financial Officer and Chief Operating Officer, McAfee
SEC CIK0000732717

AT&T Inc. reported this change in a Form 8-K, Item 5.02, filed June 16, 2026. The filing's own words are quoted above.

Other records naming Pascal Desroches

1

The outgoing officer on this record, matched by name. Career line.

2026-02-09 · 10-K signature

Pascal Desroches signed AT&T's annual report as Senior Executive Vice President and Chief Financial Officer

Also filed in June 2026

Other CFO moves on the record that month. All moves.

4 months ago· 2026-06-30TransitionBANX

ArrowMark Financial Corp. CFO transition: Katherine Jones to succeed Patrick Farrell

4 months ago· 2026-06-30InterimIMNN

Imunon, Inc. names Josh Blacher interim CFO

4 months ago· 2026-06-30TransitionRANI

Rani Therapeutics Holdings, Inc. CFO transition: Nicholas M. Maestas to succeed Svai Sanford

4 months ago· 2026-06-29InterimCVKD

Cadrenal Therapeutics, Inc. names John P. Sharp interim CFO

4 months ago· 2026-06-29TransitionGCO

Genesco Inc. CFO transition: Jonathan Collins to succeed Mimi E. Vaughn

4 months ago· 2026-06-29TransitionTNYA

Tenaya Therapeutics, Inc. CFO transition: Eric Hyllengren, M.B.A. to succeed Faraz Ali, M.B.A.

Sources

  • sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26

Something wrong about Jennifer Biry? Send a correction with the primary source.